Skip to content
PIP-2408-1.jpg

Image -

PIP-2408-1.jpg

Investors worldwide are scouring for their next big win after the door to the extremely lucrative obesity market was opened by pharmaceutical giants Novo Nordisk and Eli Lilly. Now benefiting on the Swedish stock exchange is a smaller Nordic biotech company. Photo: Pila Pharma.
go to media item
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
File format:
.jpg
Size:
5120 x 2880, 4.27 MB
Download

Related content

  • Pila Pharma, a smaller Nordic biotech company listed on the Nasdaq First North exchange in Stockholm, has enjoyed an unusually good stock market year. Photo: Pila Pharma.

    Hunt for Next Obesity Breakthrough Sends Biotech Stock Soaring

    Investors worldwide are scouring for their next big win after the door to the extremely lucrative obesity market was opened by pharmaceutical giants Novo Nordisk and Eli Lilly. Now benefiting on the Swedish stock exchange is a smaller Nordic biotech company.